The company is voluntarily recalling the product due to difficulties with the delivery system. The company is voluntarily recalling the product due to difficulties with the delivery system. AmEx ...

Avella Specialty Pharmacy announced a voluntary recall of Bevacizumab 1.25mg/0.05mL PF and Vancomycin PF (BSS) 1%. This recall is a result of concerns of sterility assurance with the pharmacy’s ...

Bevacizumab is a humanized monoclonal antibody that targets vascular endothelial growth factor. As a result of concerns for potential infusion-related hypersensitivity reactions (HSRs), initial phase ...

NHIC will allow no greater than two units for HCPCS Level II code J9035 Injection, bevacizumab, 10 mg per patient per date of service, effective for services rendered on or after Feb. 1, according to ...

Aflibercept was a less cost-effective treatment for retinal vein occlusion (RVO) compared with bevacizumab, although visual acuity outcomes were similar. Visual acuity outcomes were similar between ...

Please provide your email address to receive an email when new articles are posted on . ORLANDO, Fla. — The success of bevacizumab in changing the outcome of IOP, bleb vascularization and fibrosis ...